CDC Lists Dozens of Infectious Disease Tests as Unavailable - Top-Institutions - MDSpire

CDC Lists Dozens of Infectious Disease Tests as Unavailable

More than two dozen assays paused or discontinued, with alternative testing options noted

  • By

  • Kathryn Wighton

  • April 2, 2026

  • 2 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    Centers for Disease Control and Prevention (CDC)
    Centers for Disease Control and Prevention (CDC)

    Atlanta, GA

    Key Differentiators

    • Infectious Disease Diagnostics
    • Public Health Laboratory Testing
    • Epidemiology

  • #2

    Johns Hopkins University School of Medicine
    Johns Hopkins University School of Medicine

    Baltimore, MD

    Key Differentiators

    • Infectious Diseases
    • Clinical Microbiology
    • Diagnostic Virology

  • #3

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Infectious Diseases
    • Clinical Pathology
    • Laboratory Medicine

  • #4

    Massachusetts General Hospital (MGH) Infectious Disease Division
    Massachusetts General Hospital (MGH) Infectious Disease Division

    Boston, MA

    Key Differentiators

    • Infectious Diseases
    • Clinical Microbiology
    • Diagnostic Testing

  • #5

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Infectious Diseases
    • Clinical Microbiology
    • Public Health

Original Source(s)

CDC Lists Dozens of Infectious Disease Tests as Unavailable

  • by Kathryn Wighton

  • April 2, 2026

Related Content

Serum cytokine profiling reveals CXCL10 (IP-10) as a major predictor of severe COVID-19 outcomes in hospitalized patients during the first pandemic wave in Italy

Top 10 States With Rising Demand for Physicians

These 10 states report physician shortages, projected physician supply gaps, or physician-to-population ratios below national benchmarks.

Explainable machine learning-based mortality risk stratification for older adults with COVID-19: pinpointing core immunological biomarkers and revealing dose-threshold effects